Varun Pasumala

Varun Pasumala

Research Associate

Molecular Solutions Care Health

Profile ID RP-003-3978 Joined 2025-06-26 4 articles
0Connections
8
Total Views
4
Total Publications
86
Publication Views

About me

AMR Surveillance and Reporting

Articles(4)

Authors: Pasupuleti Kishore Kumar, Pasumala Varun, Thokala Ruchitha, Chinta Rohit Kumar, T Rama Rao

DOI: 10.32677/ijcr.v11i4.5024

Volume11
Issue4
Pages169-171
Abstract

Inflammatory plaques are a hallmark of discoid lupus erythematosus (DLE), a chronic cutaneous illness that can cause skin shrinkage and disfiguring scarring if left untreated. The best treatments, however, are not well supported by the available data. As of right now, no drugs have been authorized expressly to treat DLE. This uncommon ailment manifests as a crimson telangiectatic lesion in the oral cavity, surrounded by white patches in the mucous membrane. Occasionally, thick or thin white papillary radiating patterns are visible around the lesion as extremely thin lines. Here, we present a 24-year-old male patient with oral DLE.

Authors: Pasupuleti Kishore Kumar, Pasumala Varun, Thokala Ruchitha, Chinta Rohit Kumar, Tadikonda Rao Rama

DOI: 10.22270/jddt.v14i10.6772

Volume14
Issue10
Pages123-128
Abstract

Thrombosis is the most common condition and the world's leading cause of death due to blood clot development in blood arteries. Thromboembolism includes classification based on where the thrombus gets attached to the blood vessels. Deep vein thrombosis (DVT) and pulmonary embolism (PE) are two of the main causes of vascular death globally, making up venous thromboembolism (VTE). According to estimates, the yearly incidence rates of VTE in individuals with European ancestry vary from 104 to 183 per 100,000 person-years. Thrombus development and propagation are dependent upon the existence of anomalies in blood flow, blood vessel wall, and blood clotting components, which are together referred to as Virchow's triad. A comprehensive diagnostic approach, which includes clinical evaluation, D-dimer testing, ultrasonography, and lung scan, provided a non-invasive diagnosis for most outpatients with suspected venous thromboembolism. Anticoagulant medication is the primary and established treatment for people who have acute venous thromboembolism (VTE). Among the treatment options available, UFH & LMWH are found to be safe for the growing fetus as they appear to not cross the placenta. Oral anticoagulants targeting thrombin or factor Xa have been introduced, replacing vitamin K antagonists. In a study involving DOACs vs VKAs in patients with pre-existing heart conditions, patients receiving DOACs for non-valvular atrial fibrillation had predominantly superior efficacy and safety. Keywords: Venous thromboembolism, Anticoagulants, Deep vein thrombosis, Pulmonary embolism, Thrombus

Authors: Pasupuleti K Kumar, Thokala Ruchitha, Pasumala Varun, Chinta R Kumar, Tadikonda Rama Rao

DOI: 10.55218/jasr.2024150201

Volume15
Issue2
Pages01-05
Abstract

The two most severe metabolic consequences of diabetes mellitus (DM) are diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemia state (HHS). Type 1 and type 2 diabetics are both susceptible to these illnesses. Hyperglycemia, ketone body production, and metabolic acidosis are symptoms of DKA. Hyperosmolality, high blood glucose increase, and little to no ketosis are signs of HHS. Despite significant advancements, it has been difficult to come to a consensus on the diagnostic criteria and course of therapy for both disorders. Another difficulty is that there is a large overlap between these two extremities of the hyperglycemia crisis continuum. A thorough biochemical and clinical patient evaluation, along with prompt diagnosis and therapy, has long been recognized as being essential for symptom relief. Intravenous insulin, fluid replacement, and concurrent management of the triggering causes all form the cornerstones of therapy. Large-scale research that contributes to the definition of how hyperglycemic crises should be handled is lacking globally. A thorough analysis of the pathogenesis, diagnosis, and treatment of DKA and HHS will be provided in this article.

A RARE CASE REPORT ON MULTI-DRUG RESISTANT PNEUMONIA WITH TYPE 1 RESPIRATORY FAILURE 2025

Authors: P Kishore Kumar, Chinta Rohit Kumar, Pasumala Varun, Thokala Ruchitha, T Rama Rao

Volume14
Issue6
Pages10-13
Abstract

Multi drug-resistant (MDR) infections have become a severe problem in health care settings with causing outcomes such as extended hospitalization, mortality, financial strain on the patients etc. Even though diagnostic advancements have taken place facilitating accurate and rapid detection of specific drug resistance patterns, lack of newer drugs in combatting infections has take toll on many patients. Usually, a bacterial colony cultured from any patient’s sample being non susceptible to at least one agent in 3 or more antibiotic classes may be termed as a multi drug resistant bacteria and such infections can become fatal causing huge numbers of mortality if communicability is possible. Even endotracheal intubation can be a risk factor for acquiring pneumonia, shortly called as ventilator associated pneumonia (VAP). In this case report, the authors review a presentation of pneumonia which was found to be caused by multi drug resistant Acinetobacter sp. also causing type 1 respiratory failure in the patient

No matching articles

Try another word from the title, author or DOI.

Brief Bio

AMR Surveillance and Reporting

Affiliations

Nothing added yet.

Education

Nothing added yet.

Honors & Awards

Nothing added yet.

Society Memberships

Nothing added yet.

Expertise

Nothing added yet.

Specialty

Nothing added yet.

Other Online Pages

Scholars in the same field

RP
Rakesh Pandit
0 publications
VK
Vinay Kumar
0 publications
AD
Abhijit Das
0 publications
MM
Muxammad Mahramov
JIZZAKH POLYTECHNIC INSTITUTE
0 publications
AD
Agrita Dhyani
Veer chandra singh garhwali government institute of medical science and research
0 publications
YO
Yimkumna Ochi
0 publications
DN
DEEPTHY NAIR
0 publications
AS
Amaresh Sahoo
0 publications

Following

Nobody here yet.

Followers

Nobody here yet.

4 Publications

A RARE CASE REPORT ON MULTI-DRUG RESISTANT PNEUMONIA WITH TYPE 1 RESPIRATORY FAILURE

Authors: P Kishore Kumar, Chinta Rohit Kumar, Pasumala Varun, Thokala Ruchitha, T Rama Rao

Published in 2025

0 Contributions

Nothing added yet.

Filter